← Mechanisms of action
CTLA4
SINGLE PROTEINHomo sapiens
Preferred name: Cytotoxic T-lymphocyte protein 4 ChEMBL ↗
Linked proteins
Drugs acting on this target (61)
| Active Pharmaceutical Ingredient | Mechanism Type ▲ | Approval Status | API Type | Mechanism of Action |
|---|---|---|---|---|
| ba3071 | Antagonist | experimental | mAb | CTLA4 |
| bat4706 | Antagonist | experimental | mAb | CTLA4 |
| caldonirimab | Antagonist | experimental | mAb | CTLA4 |
| gi-101 | Antagonist | experimental | Recombinant protein | CTLA4 antagonist |
| imm27m | Antagonist | experimental | mAb | CTLA4 |
| js007 | Antagonist | experimental | mAb | CTLA4 |
| quavonlimab | Antagonist | experimental | mAb | CTLA4 |
| si-b003 | Antagonist | experimental | mAb | CTLA4 |
| xtx101 | Antagonist | experimental | mAb | CTLA4 |
| zalifrelimab | Antagonist | experimental | mAb | CTLA4 |
| anti-ctla-4/pd-1 expressing muc1-car-t cells | Immunity, passive | experimental | Cell therapy | CTLA4 immunity, passive |
| abatacept (orencia) | Inhibitor | approved | Recombinant protein | CTLA4 inhibitor |
| ad-116 | Inhibitor | experimental | mAb | CTLA4 inhibitor |
| adg116 | Inhibitor | experimental | mAb | CTLA4 inhibitor |
| adg126 | Inhibitor | experimental | mAb | CTLA4 inhibitor |
| adu-1604 | Inhibitor | experimental | mAb | CTLA4 inhibitor |
| agen1181 | Inhibitor | experimental | mAb | CTLA4 inhibitor |
| agen1884 | Inhibitor | experimental | mAb | CTLA4 inhibitor |
| ak-104 | Inhibitor | experimental | mAb | CTLA4 inhibitor |
| alpn-202 | Inhibitor | experimental | mAb | CTLA4 inhibitor |
| amp-110 | Inhibitor | experimental | mAb | CTLA4 inhibitor |
| ator-1015 | Inhibitor | experimental | mAb | CTLA4 inhibitor |
| bcd-145 | Inhibitor | experimental | mAb | CTLA4 inhibitor |
| belatacept (nujolix) | Inhibitor | approved | Recombinant protein | CTLA4 inhibitor |
| bms-986218 | Inhibitor | experimental | mAb | CTLA4 inhibitor |
| bms-986249 | Inhibitor | experimental | mAb | CTLA4 inhibitor |
| bms-986288 | Inhibitor | experimental | mAb | CTLA4 inhibitor |
| cadonilimab | Inhibitor | experimental | mAb | Cytotoxic T-lymphocyte protein 4 inhibitor |
| coya 302 | Inhibitor | experimental | mAb | CTLA4 inhibitor |
| cs1002 | Inhibitor | experimental | mAb | CTLA4 inhibitor |
| cs2009 | Inhibitor | experimental | mAb | CTLA4 inhibitor |
| ctla-4-fc fusion protein | Inhibitor | experimental | Recombinant protein | CTLA4 inhibitor |
| egl-001 | Inhibitor | experimental | Recombinant protein | CTLA4 inhibitor |
| gb268 | Inhibitor | experimental | mAb | CTLA4 inhibitor |
| giga-564 | Inhibitor | experimental | mAb | CTLA4 inhibitor |
| hbm4003 | Inhibitor | experimental | mAb | CTLA4 inhibitor |
| ibi310 | Inhibitor | experimental | mAb | CTLA4 inhibitor |
| ipilimumab (yervoy) | Inhibitor | approved | mAb | CTLA4 inhibitor |
| jk08 | Inhibitor | experimental | mAb | CTLA4 inhibitor |
| kahr-102 | Inhibitor | experimental | Recombinant protein | CTLA4 inhibitor |
| kn044 | Inhibitor | experimental | mAb | CTLA4 inhibitor |
| kn046 | Inhibitor | experimental | mAb | CTLA4 inhibitor |
| lm-168 | Inhibitor | experimental | mAb | CTLA4 inhibitor |
| lm-168 | Inhibitor | experimental | mAb | CTLA4 inhibitor |
| medi5752 | Inhibitor | experimental | mAb | CTLA4 inhibitor |
| mgd019 | Inhibitor | experimental | mAb | CTLA4 inhibitor |
| mt-8421 | Inhibitor | experimental | Cell therapy | CTLA4 inhibitor |
| onc-392 | Inhibitor | experimental | mAb | CTLA4 inhibitor |
| pd-1/ctla-4 dual functional antibody | Inhibitor | experimental | mAb | CTLA4 inhibitor |
| pd-l1/ctla4 bsab | Inhibitor | experimental | mAb | CTLA4 inhibitor |
| psb205 | Inhibitor | experimental | mAb | CTLA4 inhibitor |
| ql-1706 | Inhibitor | experimental | mAb | CTLA4 inhibitor |
| ql1706 | Inhibitor | experimental | mAb | CTLA4 inhibitor |
| quavonlimab | Inhibitor | experimental | mAb | Cytotoxic T-lymphocyte protein 4 inhibitor |
| regn4659 | Inhibitor | experimental | mAb | CTLA4 inhibitor |
| shr-8068 | Inhibitor | experimental | mAb | CTLA4 inhibitor |
| tremelimumab (Imjudo) | Inhibitor | approved | mAb | CTLA4 inhibitor |
| xmab20717 | Inhibitor | experimental | mAb | CTLA4 inhibitor |
| xmab22841 | Inhibitor | experimental | mAb | CTLA4 inhibitor |
| yh001 | Inhibitor | experimental | mAb | CTLA4 inhibitor |
| zb004 | Inhibitor | experimental | Recombinant protein | CTLA4 inhibitor |